CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q1 2022 earnings call dated May. 11, 2022 Corporate Participants: Alicia Grande — Vice President, Chief Financial...
Cara Therapeutics Inc. (NASDAQ: CARA) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Iris Francesconi — Interim Head of Investor...
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The...
ImmunoGen, Inc. (NASDAQ: IMGN) Q1 2022 earnings call dated May. 06, 2022 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications...
Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition...
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Andrea N. Flynn — Vice President, Head,...
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Ryan Crowe — Vice President of Investor...
Moderna Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President and Head...
Sage Therapeutics Inc. (NASDAQ: SAGE) Q1 2022 earnings call dated May. 03, 2022 Corporate Participants: Helen Rubinstein — Investor Relations Barry Greene — Chief...
For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development....
Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today. Total revenue decreased 6% year-over-year to $2.53 billion. GAAP net...
Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers...
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2022 earnings call dated Apr. 27, 2022 Corporate Participants: Traci McCarty — Vice President, Investor Relations...
Beyondspring, Inc. (NASDAQ: BYSI) Q4 2021 earnings call dated Apr. 14, 2022 Corporate Participants: Ashley Sierchio — Investor Relations Lan Huang — Co-founder, Chairman...
The IPO market is yet to fully recover from headwinds like the economic slowdown and Russia-Ukraine war. But activity is...
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services...
Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) Q4 2021 earnings call dated Mar. 17, 2022 Corporate Participants: Alicia Grande — Vice President, Chief Financial...
After starting the year on a high note, the IPO market is currently going through a slow phase mainly due...
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q4 2021 earnings call dated Mar. 11, 2022 Corporate Participants: Will O’Connor — Investor Relations Peter Nielsen — President,...
Avid Bioservices, Inc. (NASDAQ: CDMO) Q3 2022 earnings call dated Mar. 08, 2022 Corporate Participants: Tim Brons — Investor Relations Nicholas Green — President...
Novavax, Inc. (NASDAQ: NVAX) Q4 2021 earnings call dated Feb. 28, 2022 Corporate Participants: Silvia Taylor — Senior Vice President of Global...
